Healthcare provider profile · identity verified

James E Haine, MD

Internal Medicine · MADISON, WI · NPI 1629063110

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	615	171
Amlodipine Besylate	Amlodipine Besylate	424	113
Levothyroxine Sodium	Levothyroxine Sodium	367	83
Omeprazole	Omeprazole	297	72
Lisinopril	Lisinopril	270	78
Metformin Hcl Er	Metformin Hcl	234	55
Gabapentin	Gabapentin	233	55
Eliquis	Apixaban	199	42
Rosuvastatin Calcium	Rosuvastatin Calcium	180	48
Losartan Potassium	Losartan Potassium	166	45
Carvedilol	Carvedilol	158	37
Tamsulosin Hcl	Tamsulosin Hcl	156	40
Metoprolol Succinate	Metoprolol Succinate	155	47
Furosemide	Furosemide	139	40
Ozempic	Semaglutide	125	22
Famotidine	Famotidine	122	26
Irbesartan	Irbesartan	122	37
Oxycodone Hcl	Oxycodone Hcl	120	19
Hydrochlorothiazide	Hydrochlorothiazide	113	32
Sertraline Hcl	Sertraline Hcl	110	25
Fluticasone Propionate	Fluticasone Propionate	102	33
Trazodone Hcl	Trazodone Hcl	102	33
Simvastatin	Simvastatin	97	31
Allopurinol	Allopurinol	91	16
Clonazepam	Clonazepam	91	11
Spironolactone	Spironolactone	89	17
Venlafaxine Hcl Er	Venlafaxine Hcl	88	11
Escitalopram Oxalate	Escitalopram Oxalate	83	22
Donepezil Hcl	Donepezil Hcl	79	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	17
Warfarin Sodium	Warfarin Sodium	70	15
Pantoprazole Sodium	Pantoprazole Sodium	68	22
Pravastatin Sodium	Pravastatin Sodium	66	18
Potassium Chloride	Potassium Chloride	64	23
Trulicity	Dulaglutide	62	suppressed
Atenolol	Atenolol	61	17
Memantine Hcl	Memantine Hcl	61	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	16
Duloxetine Hcl	Duloxetine Hcl	58	17
Metoprolol Tartrate	Metoprolol Tartrate	58	12
Pregabalin	Pregabalin	58	suppressed
Metformin Hcl	Metformin Hcl	57	19
Albuterol Sulfate Hfa	Albuterol Sulfate	56	25
Ondansetron Hcl	Ondansetron Hcl	56	suppressed
Alprazolam	Alprazolam	55	15
Zolpidem Tartrate	Zolpidem Tartrate	55	14
Anastrozole	Anastrozole	54	14
Mirtazapine	Mirtazapine	54	suppressed
Alendronate Sodium	Alendronate Sodium	53	17
Quetiapine Fumarate	Quetiapine Fumarate	52	suppressed
Valsartan	Valsartan	51	14
Lorazepam	Lorazepam	50	15
Morphine Sulfate Er	Morphine Sulfate	49	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	45	suppressed
Finasteride	Finasteride	44	suppressed
Jardiance	Empagliflozin	44	13
Glipizide	Glipizide	43	11
Tramadol Hcl	Tramadol Hcl	42	suppressed
Farxiga	Dapagliflozin Propanediol	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Morphine Sulfate	Morphine Sulfate	38	suppressed
Nystatin	Nystatin	37	11
Tizanidine Hcl	Tizanidine Hcl	37	11
Prednisone	Prednisone	36	21
Buspirone Hcl	Buspirone Hcl	35	11
Ketoconazole	Ketoconazole	34	12
Olanzapine	Olanzapine	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Loperamide	Loperamide Hcl	31	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Ventolin Hfa	Albuterol Sulfate	28	12
Advair Hfa	Fluticasone Propion/Salmeterol	27	suppressed
Baclofen	Baclofen	27	suppressed
Lamotrigine	Lamotrigine	27	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Naproxen	Naproxen	26	11
Ondansetron Odt	Ondansetron	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	21
Azelastine Hcl	Azelastine Hcl	25	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	15
Celecoxib	Celecoxib	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Arnuity Ellipta	Fluticasone Furoate	20	suppressed
Buprenorphine	Buprenorphine	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Calcitriol	Calcitriol	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	16
Temazepam	Temazepam	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Liothyronine Sodium	Liothyronine Sodium	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Nitroglycerin	Nitroglycerin	17	12
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Torsemide	Torsemide	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Clopidogrel	Clopidogrel Bisulfate	16	suppressed
Novolin N	Insulin Nph Human Isophane	16	suppressed
Novolin R	Insulin Regular, Human	16	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Letrozole	Letrozole	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Amantadine	Amantadine Hcl	14	suppressed
Amoxicillin	Amoxicillin	14	13
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Levocarnitine	Levocarnitine	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Risperidone	Risperidone	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Eplerenone	Eplerenone	13	suppressed
Estradiol	Estradiol	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Cephalexin	Cephalexin	12	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Minocycline Hcl	Minocycline Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Travoprost	Travoprost	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	11	11
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Nystop	Nystatin	11	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error